Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies

被引:324
作者
Bubendorf, L [1 ]
Nocito, A [1 ]
Moch, H [1 ]
Sauter, G [1 ]
机构
[1] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland
关键词
tissue microassays; high-throughput technologies; immunohistochemistry; FISH; in situ hybridization;
D O I
10.1002/path.893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue microarray (TMA) technology allows a massive acceleration of studies correlating molecular in situ findings with clinico-pathological information. In this technique, cylindrical tissue samples are taken from up to 1000 different archival tissue blocks and subsequently placed into one empty 'recipient' paraffin block. Sections from TMA blocks can be used for all different types of in situ tissue analyses including immunohistochemistry and in situ hybridization. Multiple studies have demonstrated that findings obtained on TMAs are highly representative of their donor tissues, despite the small size of the individual specimens (diameter 0.6 mm). It is anticipated that TMAs will soon become a widely used tool for all types of tissue-based research. The availability of TMAs containing highly characterized tissues will enable every researcher to perform studies involving thousands of tumours rapidly. Therefore, TMAs will lead to a significant acceleration of the transition of basic research findings into clinical applications. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 11 条
[1]  
Bärlund M, 2000, CANCER RES, V60, P5340
[2]   Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis [J].
Bärlund, M ;
Forozan, F ;
Kononen, J ;
Bubendorf, L ;
Chen, YD ;
Bittner, ML ;
Torhorst, J ;
Haas, P ;
Bucher, C ;
Sauter, G ;
Kallioniemi, OP ;
Kallioniemi, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) :1252-1259
[3]  
BATTIFORA H, 1986, LAB INVEST, V55, P244
[4]   Hormone therapy failure in human prostate cancer:: Analysis by complementary DNA and issue microarrays [J].
Bubendorf, L ;
Kolmer, M ;
Kononen, J ;
Koivisto, P ;
Mousses, S ;
Chen, YD ;
Mahlamäki, E ;
Schraml, P ;
Moch, H ;
Willi, N ;
Elkahloun, AG ;
Pretlow, TG ;
Gasser, TC ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (20) :1758-1764
[5]  
Bubendorf L, 1999, CANCER RES, V59, P803
[6]  
DeRisi J, 1996, NAT GENET, V14, P457
[7]   Expression profiling using cDNA microarrays [J].
Duggan, DJ ;
Bittner, M ;
Chen, YD ;
Meltzer, P ;
Trent, JM .
NATURE GENETICS, 1999, 21 (Suppl 1) :10-14
[8]   Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847
[9]   High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma [J].
Moch, H ;
Schraml, P ;
Bubendorf, L ;
Mirlacher, M ;
Kononen, J ;
Gasser, T ;
Mihatsch, MJ ;
Kallioniemi, OP ;
Sauter, G .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :981-986
[10]   High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer [J].
Richter, J ;
Wagner, U ;
Kononen, J ;
Fijan, A ;
Bruderer, J ;
Schmid, U ;
Ackermann, D ;
Maurer, R ;
Alund, G ;
Knönagel, H ;
Rist, M ;
Wilber, K ;
Anabitarte, R ;
Hering, F ;
Hardmeier, T ;
Schönenberger, A ;
Flury, R ;
Jäger, P ;
Fehr, JL ;
Schraml, P ;
Moch, H ;
Mihatsch, MJ ;
Gasser, T ;
Kallioniemi, OP ;
Sauter, G .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (03) :787-794